Literature DB >> 23883939

Towards a pan-European definition of complementary and alternative medicine--a realistic ambition?

Torkel Falkenberg1, George Lewith, Paolo Roberti di Sarsina, Klaus von Ammon, Koldo Santos-Rey, Johanna Hök, Martin Frei-Erb, Jorge Vas, Reinhard Saller, Bernhard Uehleke.   

Abstract

BACKGROUND: The terms used for defining complementary and alternative medicine (CAM) including the methods, procedures and therapies vary greatly. The task of the CAMbrella working group on terminology was to explore the existing CAM terminologies and to develop a pragmatic definition of CAM that is acceptable Europe-wide. This can then be used to systematically research, e.g., its prevalence and legal status and to investigate the citizens' demands on CAM and the perspectives of providers of CAM in Europe.
METHODS: Terms and definitions were collected from both scientific and non-scientific sources. The terms and definitions identified were analysed and discussed among the CAMbrella working group participants on several occasions with the aim of arriving at a consensus.
RESULTS: We developed a proposal for a pragmatic European definition of CAM: 'Complementary and alternative medicine (CAM) utilised by European citizens represents a variety of different medical systems and therapies based on the knowledge, skills and practices derived from theories, philosophies and experiences used to maintain and improve health, as well as to prevent, diagnose, relieve or treat physical and mental illnesses. CAM has been mainly used outside conventional health care, but in some countries certain treatments are being adopted or adapted by conventional health care.'
CONCLUSION: Developing a uniform, pragmatic pan-European definition of CAM was complicated by a number of factors. These included the vast diversity of existing definitions, systems, disciplines, procedures, methods and therapies available within the EU.

Entities:  

Mesh:

Year:  2012        PMID: 23883939     DOI: 10.1159/000343812

Source DB:  PubMed          Journal:  Forsch Komplementmed        ISSN: 1661-4119


  7 in total

Review 1.  Potential Benefits of Annona muricata in Combating Cancer: A Review.

Authors:  Aidy Irman Yajid; Husna Syakirah Ab Rahman; Michael Pak Kai Wong; Wan Zainira Wan Zain
Journal:  Malays J Med Sci       Date:  2018-02-28

2.  Overview of Integrative Medicine Practices and Policies in NATO Participant Countries.

Authors:  Gabriella Hegyi; Richard P Petri; Paolo Roberti di Sarsina; Richard C Niemtzow
Journal:  Med Acupunct       Date:  2015-10-01

3.  Research methodology: choices, logistics, and challenges.

Authors:  Ian D Coulter; George Lewith; Raheleh Khorsan; Ray Kirk; Brian Mittman
Journal:  Evid Based Complement Alternat Med       Date:  2014-04-14       Impact factor: 2.629

4.  Use of Complementary and Alternative Medicine in Children with Cancer: A Study at a Swiss University Hospital.

Authors:  Tatjana Magi; Claudia E Kuehni; Loredana Torchetti; Laura Wengenroth; Sonja Lüer; Martin Frei-Erb
Journal:  PLoS One       Date:  2015-12-22       Impact factor: 3.240

5.  Usage of Complementary Medicine in Switzerland: Results of the Swiss Health Survey 2012 and Development Since 2007.

Authors:  Sabine D Klein; Loredana Torchetti; Martin Frei-Erb; Ursula Wolf
Journal:  PLoS One       Date:  2015-10-29       Impact factor: 3.240

6.  Navigating the care between two distinct cultures: a qualitative study of the experiences of Arabic-speaking immigrants in Norwegian hospitals.

Authors:  Tariq Alkhaled; Gudrun Rohde; Birgit Lie; Berit Johannessen
Journal:  BMC Health Serv Res       Date:  2022-03-26       Impact factor: 2.655

7.  High prevalence but limited evidence in complementary and alternative medicine: guidelines for future research.

Authors:  Felix H Fischer; George Lewith; Claudia M Witt; Klaus Linde; Klaus von Ammon; Francesco Cardini; Torkel Falkenberg; Vinjar Fønnebø; Helle Johannessen; Bettina Reiter; Bernhard Uehleke; Wolfgang Weidenhammer; Benno Brinkhaus
Journal:  BMC Complement Altern Med       Date:  2014-02-06       Impact factor: 3.659

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.